Biotech licensing deals to face new documentation requirements under 2026 law
Kivo says the new law brings biotechnology licensing under federal review, prompting added paperwork for deal diligence.
Kivo reports the Biotech Investment National Security Act of 2026 expands U.S. licensing deal reviews to include biotechnology. The change will impose new documentation requirements on parties involved in biotech licensing, increasing due diligence paperwork.